Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
    • UDDA Revision Series
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

April 13, 2021; 96 (15 Supplement) Saturday, April 17

Factors Guiding Choice of Novel Neurotechnological Interventions for Pediatric Drug Resistant Epilepsy: Physician and Caregiver Perspectives (2318)

Judy Illes, Viorica Hrincu, Patrick McDonald, Mary Connolly, Mark Harrison, George Ibrahim, Robert Naftel, Winston Chiong, Farhad Udwadia, Urs Ribary
First published April 13, 2021,
Judy Illes
1Neurology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Viorica Hrincu
1Neurology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick McDonald
2Medicine
3Surgery
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Connolly
6Pediatrics, BC Children’s Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Harrison
4Faculty of Pharmaceutical Sciences, University of British Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Ibrahim
7Neurosurgery, Hospital for Sick Children and Toronto Western Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Naftel
8Neurosurgery, Vanderbilt University Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Winston Chiong
9UCSF Memory and Aging Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farhad Udwadia
5University of British Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Urs Ribary
10Behavioral & Cognitive Neuroscience Institute, Simon Fraser University
11Pediatrics, BC Children’s Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Factors Guiding Choice of Novel Neurotechnological Interventions for Pediatric Drug Resistant Epilepsy: Physician and Caregiver Perspectives (2318)
Judy Illes, Viorica Hrincu, Patrick McDonald, Mary Connolly, Mark Harrison, George Ibrahim, Robert Naftel, Winston Chiong, Farhad Udwadia, Urs Ribary
Neurology Apr 2021, 96 (15 Supplement) 2318;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: To address knowledge gaps and ethical considerations surrounding the adoption of novel neurotechnological for pediatric drug resistant epilepsy (DRE).

Background: Minimally invasive and neuromodulatory interventions may be effective alternatives to conventional epilepsy surgery for pediatric DRE. Adoption of these novel treatments must accompany the priorities and values of caregivers of children with DRE. By engaging physicians and families to determine the ethical parameters, we seek to promote decision-making on this evolving technological landscape.

Design/Methods: We recruited pediatric epileptologists and neurosurgeons across Canada and the US to participate in one of four focus groups at national conferences (n=33). We recruited parents and primary caregivers of children with DRE to one of three focus groups, or to individual interviews, through clinics (n=22). Discussions were analyzed using qualitative content analysis.

Results: Major thematic branches - physicians: 1) clinical decision-making and 2) ethical considerations. Under clinical decision-making, scientific evidence and patient candidacy were significant subthemes. Ongoing seizures without intervention was a risk to neurodevelopment and safety. Under ethical considerations, resource allocation and external financial pressures were significant subthemes, having a profound impact on technology adoption and access.

Major thematic branches - families: 1) features of the intervention, 2) decision drivers, and 3) information. Under features of the intervention, parents assessed the overall risk-benefit ratio of the neurotechnology, emphasizing quality of life. Parents acknowledged the risks of doing nothing, but expressed an aversion to invasive procedures. Under decision drivers, trust in the physician was a significant subtheme. Parents were determined to overcome treatment costs; specific access concerns varied by region. Under information, personal research–especially online–dominated the subtheme.

Conclusions: Physicians and caregivers identify shared and divergent ethical and contextual factors affecting decision-making for novel neurotechnological interventions for pediatric DRE. Healthcare delivery can be maximized through the alignment of stakeholder treatment perspectives, values, and priorities.

Disclosure: The institution of Dr. Illes has received research support from NIH, CIHR, Technical Safety BC, WorkSafeBC, North Growth Foundation, Dana Foundation. Dr. Illes has received intellectual property interests from a publication relating to health care. Dr. Illes has a non-compensated relationship as a Principal Investigator, Canada Research Chair with NIH and CIHR that is relevant to AAN interests or activities. Ms. Hrincu has received personal compensation for serving as an employee of LoginRadius. The institution of Patrick McDonald has received research support from National Institutes of Health. Dr. Connolly has nothing to disclose. The institution of Mark Harrison has received research support from Canadian Institutes of Health Research. The institution of Mark Harrison has received research support from Michael Smith Foundation for Health Research. The institution of Mark Harrison has received research support from National Institutes of Health. The institution of Mark Harrison has received research support from Candian Rheumatology Association . George Ibrahim has nothing to disclose. Robert Naftel has nothing to disclose. The institution of Dr. Chiong has received research support from the National Institutes of Health. Dr. Chiong has received personal compensation in the range of $500-$4,999 for serving as a member, NeuroEthics Working Group with National Institutes of Health. Farhad Udwadia has nothing to disclose. Urs Ribary has nothing to disclose.

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Association Between Fluctuations in Blood Lipid Levels Over Time With Incident Alzheimer Disease and Alzheimer Disease–Related Dementias

Dr. Sevil Yaşar and Dr. Behnam Sabayan

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 101 (14)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise